RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1994; 72(01): 160-161
DOI: 10.1055/s-0038-1648830
DOI: 10.1055/s-0038-1648830
Letter to the Editor
Potency and In Vivo Recovery of High Purity Factor VIII Concentrates
Autoren
Weitere Informationen
Publikationsverlauf
Received 24. Juni 1992
Accepted after revision 21. März 1994
Publikationsdatum:
12. Juli 2018 (online)
-
References
- 1 Barrowcliffe TW, Watton J, Harman A, Tubbs JE, Kemball-Cook G. Potency of high purity factor VIII concentrates. Lancet 1990; ii: 124
- 2 Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131-137
- 3 Nilsson IM, Bemtorp E. Clinical efficacy of clotting factor concentrates: survival, recovery and hemostatic capacity. In: Coagulation and Blood Transfusion Smit Sibinga CTh, Das PC, Mannucci PM. (eds) Dordrecht, The Netherlands: Kluwer Academic Publishers; 1991. pp 193-206
- 4 Morfini M, Lee M, Messori A. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Thromb Haemost 1991; 66: 384-386